FDA votes against lumbar spinal stenosis device
This article was originally published in Clinica
Executive Summary
St Francis Medical Technologies' novel device for treating the debilitating degenerative spinal condition, lumbar spinal stenosis (LSS), is not ready for marketing in the US, an FDA advisory panel has concluded.